Lévai R - Search Results

1

Pre-registration efficacy study of a novel marker vaccine against classical swine fever on maternally derived antibody positive (MDA+) target animals.

Farsang A, Lévai R, Barna T, Fábián K, Blome S, Belák K, Bálint Á, Koenen F, Kulcsár G. Farsang A, et al. Among authors: levai r. Biologicals. 2017 Jan;45:85-92. doi: 10.1016/j.biologicals.2016.09.008. Epub 2016 Oct 15. Biologicals. 2017. PMID: 27756679

2

Cytokine and immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of classical swine fever virus.

Renson P, Le Dimna M, Gabriel C, Levai R, Blome S, Kulcsar G, Koenen F, Le Potier MF. Renson P, et al. Among authors: levai r. Res Vet Sci. 2014 Apr;96(2):389-95. doi: 10.1016/j.rvsc.2014.01.002. Epub 2014 Jan 31. Res Vet Sci. 2014. PMID: 24530018

3

Pre-registration efficacy study of a novel marker vaccine against classical swine fever on Maternally Derived Antibody negative (MDA-) target animals.

Lévai R, Barna T, Fábián K, Blome S, Belák K, Bálint Á, Koenen F, Kulcsár G, Farsang A. Lévai R, et al. Biologicals. 2015 Mar;43(2):92-9. doi: 10.1016/j.biologicals.2014.12.004. Epub 2015 Jan 27. Biologicals. 2015. PMID: 25637578

4

Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs.

Tignon M, Kulcsár G, Haegeman A, Barna T, Fábián K, Lévai R, Van der Stede Y, Farsang A, Vrancken R, Belák K, Koenen F. Tignon M, et al. Among authors: levai r. Vet Microbiol. 2010 Apr 21;142(1-2):59-68. doi: 10.1016/j.vetmic.2009.09.044. Epub 2009 Sep 27. Vet Microbiol. 2010. PMID: 19857935

5

Author Correction: Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers.

Sliepen K, Schermer E, Bontjer I, Burger JA, Lévai RF, Mundsperger P, Brouwer PJM, Tolazzi M, Farsang A, Katinger D, Moore JP, Scarlatti G, Shattock RJ, Sattentau QJ, Sanders RW. Sliepen K, et al. Among authors: levai rf. NPJ Vaccines. 2021 Nov 2;6(1):134. doi: 10.1038/s41541-021-00398-1. NPJ Vaccines. 2021. PMID: 34728634 Free PMC article. No abstract available.

6

Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA.

Aldon Y, McKay PF, Moreno Herrero J, Vogel AB, Lévai R, Maisonnasse P, Dereuddre-Bosquet N, Haas H, Fábián K, Le Grand R, Sahin U, Shattock RJ. Aldon Y, et al. Among authors: levai r. Mol Ther Nucleic Acids. 2021 Jun 24;25:483-493. doi: 10.1016/j.omtn.2021.06.008. eCollection 2021 Sep 3. Mol Ther Nucleic Acids. 2021. PMID: 34589271 Free PMC article.

7

Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers.

Sliepen K, Schermer E, Bontjer I, Burger JA, Lévai RF, Mundsperger P, Brouwer PJM, Tolazzi M, Farsang A, Katinger D, Moore JP, Scarlatti G, Shattock RJ, Sattentau QJ, Sanders RW. Sliepen K, et al. Among authors: levai rf. NPJ Vaccines. 2021 Aug 17;6(1):103. doi: 10.1038/s41541-021-00364-x. NPJ Vaccines. 2021. PMID: 34404812 Free PMC article.

8

How we'll survive our next computer switchover.

Levai R. Levai R. Med Econ. 2000 Apr 10;77(7):47-8, 51. Med Econ. 2000. PMID: 11010300 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters